Faculty profile

Holger Hirte

Back to faculty

Professor EmeritusOncologyMcMaster University

Holger Hirte

Professor Emeritus

Oncology

Faculty of Health Sciences

McMaster University

Hamilton, Ontario, Canada

In this role since 2022

Email ORCID

Supervision signals

Emeritus professors are retired and rarely take new students.
No graduate courses on record.
14 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.

These signals come from public records. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

345

Publications

21,595

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Academic profiles

University Profile Search on Google Scholar iDORCID OpenAlex

Social profiles

𝕏Search on X inSearch on LinkedIn 🦋Search on Bluesky ▶Search on YouTube

Contact

hirteh@HHSC.CA

Research

Research areas, by share of publications

Ovarian cancer diagnosis and treatmentMedicine
PARP inhibition in cancer therapyMedicine
Angiogenesis and VEGF in CancerBiochemistry, Genetics and Molecular Biology
HER2/EGFR in Cancer ResearchMedicine
Glioma Diagnosis and TreatmentMedicine

Research areas are derived from OpenAlex topics of their publications.

From the 150 most recent of 345 publications.

Abstract A029: Durvalumab and tremelimumab in patients with metastatic non-adenoid cystic salivary gland cancer treated in the CCTG IND.228 phase II basket trial

Winquist E, Hilton J, Kollmannsberger C, Charpentier D, Dueck D-A, Hirte H, Hotte S, Jamal R, Jang R, Maksymiuk A

Cancer Research2026

DOI: 10.1158/1538-7445.rareca26-a029

Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial

Gupta AA, Tinker A, Jonker D, Jamal R, Hirte H, Winquist EW, Chu Q, Kollmannsberger C, Wong R, Alcindor T

EClinicalMedicine20255 citations

DOI: 10.1016/j.eclinm.2024.102991

Incidence of Venous Thromboembolism in Newly Diagnosed Glioblastoma Multiforme and Associated Risk Factors: A retrospective Chart Review

Al Majarafi N, Binjabal D, Pond GR, Hirte H

2025Senior author

DOI: 10.20944/preprints202506.1194.v1

Incidence of Venous Thromboembolism in Newly Diagnosed Glioblastoma and Associated Risk Factors: A Retrospective Chart Review

Binjabal D, Al Majarafi N, Pond GR, Hirte H

Current Oncology2025Senior author

DOI: 10.3390/curroncol32080449

Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

Roth P, Gorlia T, Reijneveld JC, de Vos F, Idbaih A, Frenel J-S, Le Rhun E, Sepulveda JM, Perry J, Masucci GL

Neuro-Oncology202455 citations

DOI: 10.1093/neuonc/noae053

Incidence of venous thromboembolism in newly diagnosed glioblastoma multiforme and associated risk factors: A retrospective chart review.

Al Majarafi N, Binjabal DO, Pond GR, Hirte HW

Journal of Clinical Oncology2024Senior author

DOI: 10.1200/jco.2024.42.16_suppl.e14040

Incidence of venous thromboembolism in newly diagnosed glioblastoma multi-forme and associated risk factors: A retrospective chart review

Al Majarafi N, Binjabal DO, Pond GR, Hirte HW

Journal of Clinical Oncology2024Senior author

UPDATED RESULTS AND MOLECULAR SUBGROUP ANALYSES FROM THE RANDOMIZED PHASE 3 MIRAGE TRIAL ON MARIZOMIB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Roth P, Gorlia T, Reijneveld J, de Vos F, Idbaih A, Frenel J-S, Le Rhun E, Sepulveda J, Perry J, Masucci GL

Neuro-Oncology2023

Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification

Thompson EF, Huvila J, Jamieson A, Leung S, Lum A, Offman S, Lytwyn A, Sur ML, Hoang L, Irving J

Modern Pathology202238 citations

DOI: 10.1038/s41379-022-01165-w

Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline

Hirte H, Poon R, Yao X, May T, Ethier J-L, Petz L, Speakman J, Elit L

Current Oncology20228 citationsFirst author

DOI: 10.3390/curroncol29010022

Researchers with similar interests

Nidhi Kumar Tyagi

Oncology

Ovarian cancer diagnosis and treatment, HER2/EGFR in Cancer Research